|
|
News Breaks
|
November 20, 2009
|
| 15:05 EDT |  | NUVA |
| theflyonthewall.com: | NuVasive calls active on second day of sell off | | NuVasive is recently down $2.76 to $34.39. Potomac Research Group said that several insurance companies now consider NuVasive's flagship procedure, XLIF, as investigational. Call option volume of 2,312 contracts compares to put volume of 966 contracts according to Track Data. December option implied volatility is at 49, January is at 46; verses its 26-week average of 45 according to Track Data, suggesting larger near term price movement. :theflyonthewall.com |
|
|
News For NUVA From The Last 14 Days Check below for free stories on NUVA the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 11, 2012
|
| 12:53 EDT |  | NUVA |
| theflyonthewall.com: | Medtronic seeks interest payment and royalties from NuVasive, Bloomberg says | | Medtronic (MDT) filed a request in San Diego federal court seeking payment from NuVasive (NUVA) for interest on a past jury verdict and royalty payments form patent infringements, reports Bloomberg. Reference Link :theflyonthewall.com |
|
|
|
|
|
